Literature DB >> 28632542

Creation and Execution of a Novel Anesthesia Perioperative Care Service at a Veterans Affairs Hospital.

Bret D Alvis1, Adam B King, Pratik P Pandharipande, Liza M Weavind, Katelin Avila, Philip J Leisy, Muhammad Ajmal, Michael McHugh, Kirk A Keegan, David A Baker, Ann Walia, Christopher G Hughes.   

Abstract

Physician-led perioperative surgical home models are developing as a method for improving the American health care system. These models are novel, team-based approaches that help to provide continuity of care throughout the perioperative period. Another avenue for improving care for surgical patients is the use of enhanced recovery after surgery pathways. These are well-described methods that have shown to improve perioperative outcomes. An established perioperative surgical home model can help implementation, efficiency, and adherence to enhanced recovery after surgery pathways. For these reasons, the Tennessee Valley Healthcare System, Nashville Veterans Affairs Medical Center created an Anesthesiology Perioperative Care Service that provides comprehensive care to surgical patients from their preoperative period through the continuum of their hospital course and postdischarge follow-up. In this brief report, we describe the development, implementation, and preliminary outcomes of the service.

Entities:  

Mesh:

Year:  2017        PMID: 28632542     DOI: 10.1213/ANE.0000000000001930

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  The evidence base for US joint commission hospital accreditation standards: cross sectional study.

Authors:  Sarah A Ibrahim; Kelly A Reynolds; Emily Poon; Murad Alam
Journal:  BMJ       Date:  2022-06-23

2.  Implementing ERAS: how we achieved success within an anesthesia department.

Authors:  Dan B Ellis; Aalok Agarwala; Elena Cavallo; Pam Linov; Michael K Hidrue; Marcela G Del Carmen; Rachel Sisodia
Journal:  BMC Anesthesiol       Date:  2021-02-05       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.